Data support potential of isaralgagene civaparvovec as a one-time, well tolerated and durable Fabry disease gene therapy to provide meaningful, multi-organ clinical benefits that could fundamentally s ...
The wait is over. Disney Experiences chairman Josh D’Amaro will succeed Bob Iger as the entertainment giant’s next CEO, the ...
Hubbell Incorporated (NYSE: HUBB) today reported operating results for the fourth quarter and full year ended December 31, 2025. "Hubbell deliver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results